FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5348511000001102: Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
27275101000001113 Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
93214701000001115 Cilest 35microgram/250microgram tablets (Waymade Healthcare Plc) 63 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Is a Norgestimate 250microgram / Ethinylestradiol 35microgram tablets 63 tablet true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Is pack of Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has active ingredient Norgestimate false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has AMP Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has specific active ingredient Norgestimate true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Cilest 250microgram / 35microgram tablets (PI) (Waymade Ltd) 63 tablet 3 x 21 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start